# A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant

> **NCT02436460** · PHASE1 · TERMINATED · sponsor: **AbGenomics B.V Taiwan Branch** · enrollment: 4 (actual)

## Conditions studied

- Acute Graft Versus Host Disease

## Interventions

- **BIOLOGICAL:** AbGn-168H

## Key facts

- **NCT ID:** NCT02436460
- **Lead sponsor:** AbGenomics B.V Taiwan Branch
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Re-initiate a new trial per the discussion with FDA
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02436460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02436460, "A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02436460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*